George Lawrence Mikan III Sells 12,440 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 12,440 shares of the firm’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the transaction, the chief executive officer now owns 249,454 shares in the company, valued at approximately $1,529,153.02. This trade represents a 4.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

George Lawrence Mikan III also recently made the following trade(s):

  • On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The shares were sold at an average price of $6.93, for a total value of $91,337.40.
  • On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total value of $11,324.24.
  • On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
  • On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34.
  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Stock Down 7.4 %

Shares of NYSE NEUE opened at $4.71 on Tuesday. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $7.66. The company has a market cap of $38.98 million, a P/E ratio of -0.09 and a beta of 0.56. The business’s 50 day moving average is $7.21 and its two-hundred day moving average is $6.01.

Hedge Funds Weigh In On NeueHealth

A number of institutional investors and hedge funds have recently bought and sold shares of NEUE. Northern Trust Corp grew its position in NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after purchasing an additional 13,074 shares during the last quarter. Virtu Financial LLC acquired a new stake in NeueHealth during the fourth quarter worth about $76,000. Finally, Partners Group Holding AG acquired a new stake in NeueHealth during the third quarter worth about $463,000. Institutional investors own 63.88% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

Get Our Latest Stock Report on NeueHealth

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Stories

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.